Hyderabad Telangana, India

Anish Anil Gupta

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anish Anil Gupta. Retrieved from https://idiyas.com/inventor/anish-anil-gupta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anish Anil Gupta: Innovator in Pharmaceutical Chemistry

Introduction

Anish Anil Gupta is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid-state forms of important therapeutic compounds.

Latest Patents

Anish holds a patent for "Solid state forms of dasatinib and processes for their preparation." This invention provides crystalline forms of (R)-propylene glycol solvate of dasatinib and (S)-propylene glycol solvate of dasatinib. His innovative work in this area has the potential to enhance the efficacy and stability of dasatinib, a drug used in cancer treatment.

Career Highlights

Anish Anil Gupta is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality in drug development. His role at the company allows him to contribute to groundbreaking research and development efforts in the pharmaceutical industry.

Collaborations

Anish has collaborated with esteemed colleagues such as Satyanarayana Thirunahari and Srividya Ramakrishnan. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical formulations.

Conclusion

Anish Anil Gupta's work exemplifies the spirit of innovation in the pharmaceutical sector. His contributions, particularly in the development of solid-state forms of dasatinib, highlight the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…